DE VITA, GABRIELLA
DE VITA, GABRIELLA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Role of wnt4 in thyroid cancer
2009 DE MENNA, Marta; Mancini, D; Ferraro, A; DI LAURO, Roberto; DE VITA, Gabriella
miR-21 deregulation in thyroid cancer
2008 Frezzetti, Daniela; Guerra, C; Barbacid, M; DI LAURO, Roberto; DE VITA, Gabriella
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells.
1995 Califano, D.; Monaco, C.; DE VITA, Gabriella; D'Alessio, A.; Dathan, N. A.; Possenti, R.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; de Franciscis, V.
A mammalian microRNA expression atlas based on small RNA library sequencing.
2007 Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, Ao; Landthaler, M; Lin, C; Socci, Nd; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, Ru; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, M; Weir, Db; Choksi, R; DE VITA, Gabriella; Frezzetti, D; Trompeter, Hi; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; DI LAURO, Roberto; Wernet, P; Macino, G; Rogler, Ce; Nagle, Jw; J, Ju; Papavasiliou, Fn; Benzing, T; Lichter, P; Tam, W; Brownstein, Mj; Bosio, A; Borkhardt, A; Russo, Jj; Sander, C; Zavolan, M; Tuschl, T.
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
A mutated p53 gene alters thyroid cell differentiation
1995 S., Battista; M. L., Martelli; M., Fedele; G., Chiappetta; F., Trapasso; DE VITA, Gabriella; C., Battaglia; Santoro, Massimo; G., Viglietto; J. A., Fagin; Fusco, Alfredo
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase
2007 DE FALCO, V; Castellone, Md; DE VITA, Gabriella; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells.
1995 D'Alessio, A; DE VITA, Gabriella; Cal, G; Nitsch, Lucio; Fusco, Alfredo; Vecchio, G; Santelli, G; Santoro, M; DE FRANCISCIS, V.
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
modello animale per lo studio di sostanze ad attività cardioterapeutica ed anti-ipertensiva
2004 Potenza, N; DI LAURO, Roberto; DE VITA, Gabriella; Lembo, G.
Molecular heterogeneity of RET loss of function in Hirschsprung's disease
1996 Carlomagno, F.; DE VITA, Gabriella; Berlingieri, M. T.; Defranciscis, V.; Melillo, ROSA MARINA; Colantuoni, V.; Kraus, M. H.; Difiore, P. P.; Fusco, Alfredo; Santoro, M.
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells
1996 D., Califano; D'Alessio, A.; COLUCCI DAMATO, L.; DE VITA, Gabriella; Monaco, C.; Santelli, G.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.; DE FRANCISCIS, V.
Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects
2000 DE VITA, Gabriella; Berlingieri, Mt; Visconti, R; Castellone, Md; Viglietto, G; Baldassarre, G; Zannini, M; Bellacosa, A; Tsichlis, Pn; Fusco, Alfredo; Santoro, Massimo
Dose-dependent inhibition of thyroid differentiation by RAS oncogenes.
2005 DE VITA, Gabriella; Bauer, L; DA COSTA, Vm; DE FELICE, Mario; Baratta, Mg; DE MENNA, M; DI LAURO, Roberto
Coordinate Regulation of Hox Genes In Human Hematopoietic-cells
1991 M. C., Magli; P., Barba; A., Celetti; DE VITA, Gabriella; C., Cillo; E., Boncinelli
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation.
2009 Talotta, F.; Cimmino, A.; Matarazzo, M. R.; Casalino, L.; DE VITA, Gabriella; D'Esposito, M.; DI LAURO, Roberto; Verde, P.
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.
1996 D., Califano; A., D'Alessio; G. L., Colucci D'Amato; DE VITA, Gabriella; C., Monaco; G., Santelli; P. P., Di Fiore; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; V. d., Franciscis
2 Point Mutations Are Responsible For G6pd-polymorphism In Sardinia
1989 DE VITA, Gabriella; M., Alcalay; M., Sampietro; M. D., Cappelini; G., Fiorelli; D., Toniolo
Wnt4 inhibits cell motility induced by oncogenic Ras
2013 DE MENNA, Marta; V., D'Amato; A., Ferraro; Fusco, Alfredo; DI LAURO, Roberto; Garbi, Corrado; DE VITA, Gabriella
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Role of wnt4 in thyroid cancer | 1.5 Abstract in rivista | 2009 | DE MENNA, Marta; Mancini, D; Ferraro, A; DI LAURO, Roberto; DE VITA, Gabriella | |
| miR-21 deregulation in thyroid cancer | 1.5 Abstract in rivista | 2008 | Frezzetti, Daniela; Guerra, C; Barbacid, M; DI LAURO, Roberto; DE VITA, Gabriella | |
| Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. | 1.1 Articolo in rivista | 1995 | Califano, D.; Monaco, C.; DE VITA, Gabriella; D'Alessio, A.; Dathan, N. A.; Possenti, R.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; de Franciscis, V. | |
| A mammalian microRNA expression atlas based on small RNA library sequencing. | 1.1 Articolo in rivista | 2007 | Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, Ao; Landthaler, M; Lin, C; Socci, Nd; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, Ru; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, M; Weir, Db; Choksi, R; DE VITA, Gabriella; Frezzetti, D; Trompeter, Hi; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; DI LAURO, Roberto; Wernet, P; Macino, G; Rogler, Ce; Nagle, Jw; J, Ju; Papavasiliou, Fn; Benzing, T; Lichter, P; Tam, W; Brownstein, Mj; Bosio, A; Borkhardt, A; Russo, Jj; Sander, C; Zavolan, M; Tuschl, T. | |
| The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1.1 Articolo in rivista | 1997 | Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo | |
| A mutated p53 gene alters thyroid cell differentiation | 1.1 Articolo in rivista | 1995 | S., Battista; M. L., Martelli; M., Fedele; G., Chiappetta; F., Trapasso; DE VITA, Gabriella; C., Battaglia; Santoro, Massimo; G., Viglietto; J. A., Fagin; Fusco, Alfredo | |
| RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase | 1.1 Articolo in rivista | 2007 | DE FALCO, V; Castellone, Md; DE VITA, Gabriella; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo | |
| Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. | 1.1 Articolo in rivista | 1995 | D'Alessio, A; DE VITA, Gabriella; Cal, G; Nitsch, Lucio; Fusco, Alfredo; Vecchio, G; Santelli, G; Santoro, M; DE FRANCISCIS, V. | |
| Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival | 1.1 Articolo in rivista | 2000 | De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M. | |
| Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease | 1.1 Articolo in rivista | 1998 | Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M. | |
| modello animale per lo studio di sostanze ad attività cardioterapeutica ed anti-ipertensiva | 6.1 Brevetto | 2004 | Potenza, N; DI LAURO, Roberto; DE VITA, Gabriella; Lembo, G. | |
| Molecular heterogeneity of RET loss of function in Hirschsprung's disease | 1.1 Articolo in rivista | 1996 | Carlomagno, F.; DE VITA, Gabriella; Berlingieri, M. T.; Defranciscis, V.; Melillo, ROSA MARINA; Colantuoni, V.; Kraus, M. H.; Difiore, P. P.; Fusco, Alfredo; Santoro, M. | |
| A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells | 1.1 Articolo in rivista | 1996 | D., Califano; D'Alessio, A.; COLUCCI DAMATO, L.; DE VITA, Gabriella; Monaco, C.; Santelli, G.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.; DE FRANCISCIS, V. | |
| Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects | 1.1 Articolo in rivista | 2000 | DE VITA, Gabriella; Berlingieri, Mt; Visconti, R; Castellone, Md; Viglietto, G; Baldassarre, G; Zannini, M; Bellacosa, A; Tsichlis, Pn; Fusco, Alfredo; Santoro, Massimo | |
| Dose-dependent inhibition of thyroid differentiation by RAS oncogenes. | 1.1 Articolo in rivista | 2005 | DE VITA, Gabriella; Bauer, L; DA COSTA, Vm; DE FELICE, Mario; Baratta, Mg; DE MENNA, M; DI LAURO, Roberto | |
| Coordinate Regulation of Hox Genes In Human Hematopoietic-cells | 1.1 Articolo in rivista | 1991 | M. C., Magli; P., Barba; A., Celetti; DE VITA, Gabriella; C., Cillo; E., Boncinelli | |
| An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. | 1.1 Articolo in rivista | 2009 | Talotta, F.; Cimmino, A.; Matarazzo, M. R.; Casalino, L.; DE VITA, Gabriella; D'Esposito, M.; DI LAURO, Roberto; Verde, P. | |
| A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. | 1.1 Articolo in rivista | 1996 | D., Califano; A., D'Alessio; G. L., Colucci D'Amato; DE VITA, Gabriella; C., Monaco; G., Santelli; P. P., Di Fiore; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; V. d., Franciscis | |
| 2 Point Mutations Are Responsible For G6pd-polymorphism In Sardinia | 1.1 Articolo in rivista | 1989 | DE VITA, Gabriella; M., Alcalay; M., Sampietro; M. D., Cappelini; G., Fiorelli; D., Toniolo | |
| Wnt4 inhibits cell motility induced by oncogenic Ras | 1.1 Articolo in rivista | 2013 | DE MENNA, Marta; V., D'Amato; A., Ferraro; Fusco, Alfredo; DI LAURO, Roberto; Garbi, Corrado; DE VITA, Gabriella |